These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32561913)

  • 1. COVID-19 and the Renin-Angiotensin-Aldosterone System.
    Naik GOA
    Clin Infect Dis; 2021 Mar; 72(6):1105-1107. PubMed ID: 32561913
    [No Abstract]   [Full Text] [Related]  

  • 2. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.
    Conversano A; Melillo F; Napolano A; Fominskiy E; Spessot M; Ciceri F; Agricola E
    Hypertension; 2020 Aug; 76(2):e10-e12. PubMed ID: 32383626
    [No Abstract]   [Full Text] [Related]  

  • 3. Renin-angiotensin-aldosterone system inhibitors to treat COVID-19?
    Henry RA
    CMAJ; 2020 Jun; 192(26):E728. PubMed ID: 32601254
    [No Abstract]   [Full Text] [Related]  

  • 4. A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19.
    Usman MS; Siddiqi TJ; Khan MS; Ahmed A; Ali SS; Michos ED; Hall ME; Krasuski RA; Greene SJ; Butler J; Alkhouli M
    Am J Cardiol; 2020 Sep; 130():159-161. PubMed ID: 32624189
    [No Abstract]   [Full Text] [Related]  

  • 5. Renin-angiotensin system blockers and COVID-19.
    Vidal-Petiot E; Gault N
    BMC Med; 2021 Jun; 19(1):136. PubMed ID: 34082752
    [No Abstract]   [Full Text] [Related]  

  • 6. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.
    Guo X; Zhu Y; Hong Y
    Hypertension; 2020 Aug; 76(2):e13-e14. PubMed ID: 32458694
    [No Abstract]   [Full Text] [Related]  

  • 7. Update Alert 6: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.
    Mackey K; Kansagara D; Vela K
    Ann Intern Med; 2021 Jan; 174(1):W17. PubMed ID: 33253036
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of ACE inhibitors/angiotensin receptor blockers in COVID-19 patients.
    Sriram K; Insel PA
    Am J Physiol Lung Cell Mol Physiol; 2020 Jul; 319(1):L37-L38. PubMed ID: 33496632
    [No Abstract]   [Full Text] [Related]  

  • 9. SARS-CoV-2 effects on the renin-angiotensin-aldosterone system, therapeutic implications.
    Ye Q; Lai EY; Luft FC; Persson PB; Mao J
    Acta Physiol (Oxf); 2021 Apr; 231(4):e13608. PubMed ID: 33350096
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiac Involvement in COVID-19].
    Sugraliyev AB
    Kardiologiia; 2021 May; 61(4):15-23. PubMed ID: 33998404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.
    Zhou F; Liu YM; Xie J; Li H; Lei F; Yang H; Qin JJ; Cai J; Zhang XJ; Wu B; Xia M; Xiang D; Yang C; Ma X; Xu Q; Lu Z; Lu H; Xia X; Wang D; Liao X; Peng G; Yang J; Huang X; Zhang BH; Yuan Y; Wei X; Liu PP; Wang Y; Zhang P; She ZG; Xia J; Li H
    Hypertension; 2020 Aug; 76(2):e15-e17. PubMed ID: 32493070
    [No Abstract]   [Full Text] [Related]  

  • 12. Heartbeat: interaction of renin-angiotensin-aldosterone blocking drugs with COVID-19 disease susceptibility and severity.
    Otto CM
    Heart; 2020 Oct; 106(19):1451-1453. PubMed ID: 32928982
    [No Abstract]   [Full Text] [Related]  

  • 13. Do the Meta-Analyses Provide a Clean Bill of Health to the Use of Renin-angiotensin System Inhibitors in Coronavirus Disease 2019 (COVID-19)?
    Kow CS; Hasan SS
    Clin Infect Dis; 2021 Jul; 73(1):164-165. PubMed ID: 32770237
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic.
    Kow CS; Hasan SS
    Expert Rev Cardiovasc Ther; 2021 Jan; 19(1):99-100. PubMed ID: 33112190
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2.
    Buckley LF; Cheng JWM; Desai A
    J Cardiovasc Pharmacol; 2020 Jun; 75(6):526-529. PubMed ID: 32301766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.
    Brojakowska A; Narula J; Shimony R; Bander J
    J Am Coll Cardiol; 2020 Jun; 75(24):3085-3095. PubMed ID: 32305401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of the renin-angiotensin-aldosterone system and COVID-19 in critically ill elderly patients.
    Jung C; Bruno RR; Wernly B; Joannidis M; Oeyen S; Zafeiridis T; Marsh B; Andersen FH; Moreno R; Fernandes AM; Artigas A; Pinto BB; Schefold J; Wolff G; Kelm M; De Lange DW; Guidet B; Flaatten H; Fjølner J;
    Eur Heart J Cardiovasc Pharmacother; 2021 Jan; 7(1):76-77. PubMed ID: 32645153
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19, hypertension, and renin-angiotensin-aldosterone system inhibitors: Much ado about nothing or real problem to be solved?
    Tadic M; Cuspidi C
    J Clin Hypertens (Greenwich); 2020 Nov; 22(11):1984-1986. PubMed ID: 32951351
    [No Abstract]   [Full Text] [Related]  

  • 19. The renin-angiotensin-aldosterone system inhibitors in COVID-19: from acidosis to ventilation and immunity.
    Liao WH; Yang GG; Henneberg M
    Swiss Med Wkly; 2020 Nov; 150():w20444. PubMed ID: 33306813
    [No Abstract]   [Full Text] [Related]  

  • 20. The other possible mechanism of the benefits of RAAS inhibition in the athogenesis of COVID-19.
    Gupta N; Patel K; Gupta R
    Clin Cardiol; 2020 Dec; 43(12):1349. PubMed ID: 33174213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.